HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covid-19 Disrupting Supply Chains Short-Term, Could Spark Long-Term Procurement Shifts

Executive Summary

UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.

You may also be interested in...



Fragrance Creators Association Highlights Industry’s Role In Answering COVID-19 Needs

The US fragrance industry advocate is promoting the efforts of its members to maintain supplies of cleaning and sanitizing products amid the COVID-19 pandemic. Across the personal- and home-care sectors, companies are going to extra lengths to put disinfectants in the hands of those in need.  

In Covid-19 Storm, Supplement Manufacturers' Safe Harbor Could Be Qualifying New Suppliers

US manufacturers losing ingredient supplies from China may need to qualify more suppliers, potentially requiring tests of all lots, says EAS Consulting. Contract and other manufacturers also should identify alternative sources for materials they receive from China and prepare for shortages from other countries.

No Shortage Of OTC Drugs In German Pharmacies Due To Coronavirus

German pharmacies remain fully stocked with OTC medicines, according to the president of the country's pharmacists' association, ABDA. 

Related Content

Topics

UsernamePublicRestriction

Register

RS149783

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel